Literature DB >> 12832115

Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.

Andrew Stevenson1, Mark Roberts.   

Abstract

Bordetella pertussis and Bordetella bronchiseptica are respiratory pathogens of humans and animals respectively. Unlike many bacteria, they are able to efficiently colonise healthy ciliated respiratory mucosa. This characteristic of Bordetella spp. can potentially be exploited to develop efficient live vaccines and vectors for delivery of heterologous antigens to the respiratory tract. Here we review the progress in this area.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12832115     DOI： 10.1016/S0928-8244(03)00068-3

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN： 0928-8244


  10 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

3.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

5.  Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica.

Authors:  Neelima Sukumar; Cheraton F Love; Matt S Conover; Nancy D Kock; Purnima Dubey; Rajendar Deora
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

6.  Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.

Authors:  M Mohamadzadeh; T Duong; S J Sandwick; T Hoover; T R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

7.  Live bacterial vaccines--a review and identification of potential hazards.

Authors:  Ann Detmer; Jacob Glenting
Journal:  Microb Cell Fact       Date:  2006-06-23       Impact factor: 5.328

8.  Colonic immune stimulation by targeted oral vaccine.

Authors:  Mahesh Kathania; Mojgan Zadeh; Yaíma L Lightfoot; Robert M Roman; Bikash Sahay; Jeffrey R Abbott; Mansour Mohamadzadeh
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Heterologous expression of porcine reproductive and respiratory syndrome virus glycoprotein 5 in Bordetella bronchisepticaaroA mutant.

Authors:  Sang Ik Park; Ja Young Seo; Tae Jung Kim
Journal:  J Vet Med Sci       Date:  2016-06-24       Impact factor: 1.267

Review 10.  Lacticaseibacillus rhamnosus: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control.

Authors:  Moloko G Mathipa-Mdakane; Mapitsi S Thantsha
Journal:  Foods       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.